Study details
Enrolling now
Adjuvant Curcumin Trial
yair lotan
NCT IDNCT02064673ClinicalTrials.gov data as of Apr 2026
Phase
Phase 3
Target enrollment
608
Study length
about 15 years
Ages
30–80
Sex
Male only
Locations
1 site in TX
About this study
Researchers are testing whether adding curcumin to standard treatment improves the time before prostate cancer returns after surgery. The trial will involve men who have had radical prostatectomy and are being treated with a treatment.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Curcumin
- 2.Take placebo
PhasePhase 3
DrugCurcumin
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low9%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
dietary supplement
Drug routes
oral (Oral Capsule)
Body systems
Oncology